Home News About Partners Contact  

Clinical Research IT

Gerry Nesbitt, CEO

CLIRINX is a company dedicated to advancing epilepsy and rare disease research through advanced IT tools.

Empowering researchers in the field of medical science, we specialize in delivering cutting-edge, 21CFR11-compliant web-based tools designed for seamless study management, precise electronic data collection, and intuitive participant portals. Our comprehensive suite of IT solutions extends to expert support for patient registries, natural history studies, clinical trial readiness assessments, and diverse research endeavors. With our assistance, researchers can confidently advance their projects, driving significant contributions to the ongoing advancement of medical research and scientific discovery.

IT for Rare Disease Research

Welcome to CLIRINX! We're dedicated to advancing epilepsy and rare disease research through improved IT tools. Whether you're a researcher, advocate, or seeking resources, we're here to enhance your data collection process.

Registries & Natural Hx Studies

CLIRINX provides IT expertise for patient registries, natural history studies, clinical trial readiness, and research. Our expert team guides researchers through the IT components from study design to close-out, committed to advancing epilepsy and rare disease research.

Team Science

We offer 21CFR11-compliant web tools to support research, speeding up discovery for new cures and treatments. Our range includes study management, data collection, and participant portals, among other advanced IT solutions. Dedicated to internet-based research, team science, and disease advocacy.

Our Customers

Emory UniversityChildrenUniversity of MelbourneLurie/PCORIDEE-P ConnectionsCASK Gene FoundationInchstoneFamilieSCN2AFamilieSCN2ANorthwestern UniversityChildrenLurie ChildrenRett Syndrome Research TrustDravet FoundationBio Pharm SolutionsBaylor College of MedicineKCNQ2 Jack Prebaz Foundation


Larry Sauter AwardTech Excellence Award 2022 FinalistTech Excellence Award 2019 FinalistBio-IT World Best Practices Award 2018SFA Innovator of the YearIrish Export Assoc. AwardsBlackKnight AwardsDatSci Data Science AwardsBank of Ireland Start-up AwardsBank of Ireland Start-up AwardsSFA ShowcaseSmall Firms Assoc.Irish Med. Devices Assoc.



Protecting your data

BioinformaticsSecurity measures include SSL (encryption), encryption of data at rest, unique user names and passwords, single sign-on (Okta), role based access, digital signatures, full audit log and data change history, version controlled CRFs and study documents, restricted/encrypted PHI fields, two-factor authentication, multi-Blockchain document timestamps, IP/geolocation restrictions, OS level security, servers only accessible behind firewall or SSH with private key encryption. We also have Cyber and PI Insurance to protect our business and our customers. All these security and privacy features will help to support your HIPAA and 21CFR11 compliance efforts.

You own the data you collect. And, unlike some other software providers, CLIRINX will never analyze, share or sell the data you collect using the CLIRINX software.

Recent News

Jul 1, 2024 The RDDR is now live. https://theRDDR.org

Jun 1, 2024 Coming soon...

Apr 24, 2024 CLIRINX & CRID feature in new major SCN2A-related publication.

Mar 20, 2024 CRID 'Clinical Research ID' hits 4000 CRID identifiers!